Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 10/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29940236 | 0.84 | SSTR5 (0.59) | SSTR5KCNH2 | |
| SCHEMBL28336722 | 0.79 | SCN9A (0.54) | SSTR5FFAR1KCNH2SCN9ASRD5A2 | |
| Trifluoroacetic Acid SCHEMBL29940320 | 0.77 | SSTR5 (0.79) | SSTR5KCNH2 | |
| Trifluoroacetic Acid SCHEMBL29940225 | 0.76 | SSTR5 (0.54) | SSTR5FFAR1KCNH2SCN9AMRGPRX4 | |
| SCHEMBL28338275 | 0.75 | SCN9A (0.66) | SSTR5FFAR1KCNH2SCN9AMRGPRX4 | |
| SCHEMBL14956935 | 0.73 | SSTR5 (1.00) | SSTR5 | |
| SCHEMBL12182451 | 0.73 | SSTR5 (0.64) | SSTR5MGLL | |
| SCHEMBL17422990 | 0.73 | SCN9A (0.66) | SSTR5FFAR1SCN9AMRGPRX4 | |
| Trifluoroacetic Acid SCHEMBL29940329 | 0.73 | SSTR5 (0.69) | SSTR5KCNH2 | |
| SCHEMBL17423165 | 0.72 | SCN9A (0.66) | SSTR5FFAR1SCN9AMGLLMRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215787-A | Somatostatin receptor 5 antagonists and uses thereof | 中国科学院上海药物研究所 | 2022-10-21 | — | — | CN | disclosed |